Matsuda Masaru 4
4 · Arcutis Biotherapeutics, Inc. · Filed Nov 21, 2025
Insider Transaction Report
Form 4
Matsuda Masaru
See Remarks
Transactions
- Sale
Common Stock
2025-11-19$28.50/sh−1,561$44,489→ 151,476 total - Sale
Common Stock
2025-11-19$27.95/sh−989$27,647→ 153,037 total
Footnotes (3)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $27.21 to $28.21, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.24 to $28.95, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.